Commission Implementing Regulation (EU) 2026/747 of 31 March 2026 approving the active substance bixlozone in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council, and amending Commission Implementing Regulation (EU) No 540/2011